Pharmacological Treatment of Comorbid Attention Deficit Hyperactivity Disorder (ADHD)
WebcastFaculty
OVERVIEW
Pharmacological Treatment of Comorbid Attention Deficit Hyperactivity Disorder (ADHD) is organized by National Association for Continuing Education (NACE) and will be held during Aug 01, 2016 - Jul 31, 2018.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1 AMA PRA Category I Credits.
Conference Description:
ADHD is often comorbid with one or a cluster of other psychological disorders. In this one hour CME session, primary care professionals will learn the list of psychological disorders that frequently occur with ADHD, the order of treatment of co-occurring conditions, and the available medications for multiple conditions, and side effects which need to be balanced in dosing and polypharmacy.
Conference Objectives are:
• Begin screening for ADHD in adult patients, prompted by the more obvious diagnosis of comorbid disorders such as depression, anxiety, substance abuse, and more.
• Treat ADHD effectively with medications, when present with comorbid disorders, and in a preferred order of treatment.
• Cite the important benefits of treating ADHD as early as possible in a patient’s life, to prevent complications of untreated ADHD down the road.
• Refer patients for adjunct treatments who suffer from identifiable dysfunctions that are not improved with ADHD medications.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1 AMA PRA Category I Credits.
Conference Description:
ADHD is often comorbid with one or a cluster of other psychological disorders. In this one hour CME session, primary care professionals will learn the list of psychological disorders that frequently occur with ADHD, the order of treatment of co-occurring conditions, and the available medications for multiple conditions, and side effects which need to be balanced in dosing and polypharmacy.
Conference Objectives are:
• Begin screening for ADHD in adult patients, prompted by the more obvious diagnosis of comorbid disorders such as depression, anxiety, substance abuse, and more.
• Treat ADHD effectively with medications, when present with comorbid disorders, and in a preferred order of treatment.
• Cite the important benefits of treating ADHD as early as possible in a patient’s life, to prevent complications of untreated ADHD down the road.
• Refer patients for adjunct treatments who suffer from identifiable dysfunctions that are not improved with ADHD medications.
Additional details will be posted as soon as they are available.
SPECIALITIES
Psychiatry
Quick Links